Can 3-Tesla Pelvic Phased-Array Multiparametric MRI Avoid Unnecessary Repeat Prostate Biopsy in Patients With PSA < 10 ng/mL?

Clinical Genitourinary Cancer - Tập 13 Số 1 - Trang e27-e30 - 2015
Pietro Pepe1, Antonio Garufi2, Giandomenico Priolo2, Michele Pennisi1
1Urology Unit, Cannizzaro Hospital, Catania, Italy
2Imaging Department, Cannizzaro Hospital, Catania, Italy

Tóm tắt

Từ khóa


Tài liệu tham khảo

Chun, 2010, Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature, Eur Urol, 58, 851, 10.1016/j.eururo.2010.08.041

Pepe, 2007, Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation, Urology, 70, 1131, 10.1016/j.urology.2007.07.068

Epstein, 1994, Pathological and clinical findings to predict tumor extent of non palpable (stage T1c) prostate cancer, JAMA, 271, 368, 10.1001/jama.1994.03510290050036

Pinto, 2011, Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging, J Urol, 186, 1281

Franiel, 2011, Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least on US-guided biopsy with a negative finding. Multiparametric MR imaging for detection and biopsy planning, Radiology, 259, 162, 10.1148/radiol.10101251

Hambrock, 2010, Magnetic resonance imaging-guided prostate biopsy in men with repeat negative biopsies and increased prostate-specific antigen, J Urol, 185, 520

Roethke, 2014, Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla, Eur Radiol, 24, 344, 10.1007/s00330-013-3017-5

Rosenkrantz, 2012, Prostate cancer foci detected on multiparametric resonance imaging are distinct from those not detected, J Urol, 187, 2032

Quentin, 2012, Evaluation of a structured report of functional prostate magnetic resonance imaging in patients with suspicion for prostate cancer or under active surveillance, Urol Int, 89, 25, 10.1159/000338808

Hambrock, 2012, Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance image-guided biopsies versus systematic 10-core transrectal ultrasound prostate biopsy, Eur Urol, 61, 177, 10.1016/j.eururo.2011.08.042

Turkbey, 2011, Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MRI images?, Radiology, 258, 488, 10.1148/radiol.10100667

Turkbey, 2010, Prostate cancer: value of multiparametric MRI imaging at 3 T for detection-histopathologic correlation, Radiology, 255, 89, 10.1148/radiol.09090475

Arsov, 2012, Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot study, Anticancer Res, 32, 1087

Turkbey, 2012, Multiparametric MRI and prostate cancer diagnosis and risk stratification, Curr Opin Urol, 22, 310, 10.1097/MOU.0b013e32835481c2

Pepe, 2013, Prostate cancer detection at repeat biopsy biopsy: can pelvic phased-array multiparametric MRI replace saturation biopsy?, Anticancer Res, 33, 1195

Sonn, 2013, Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device, J Urol, 189, 86

Komai, 2013, High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy, J Urol, 190, 867

Lawrentschuck, 2009, The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies elevated prostatic-specific antigen levels, BJU Int, 103, 730, 10.1111/j.1464-410X.2008.08205.x

Hoeks, 2014, Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study, Invest Radiol, 49, 165, 10.1097/RLI.0000000000000008

Pepe, 2010, Incidence of insignificant prostate cancer using free/total PSA: results of a case-finding protocol on 14,453 patients, Prostate Cancer Prostatic Dis, 13, 316, 10.1038/pcan.2010.29

Pepe, 2010, Is a single focus of low grade prostate cancer, diagnosed on saturation biopsy, predictive of clinically insignificant cancer?, Urol Int, 84, 440, 10.1159/000296293

Puech, 2013, Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy–prospective multicenter study, Radiology, 268, 461, 10.1148/radiol.13121501

Pinkhasov, 2012, Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases, BJU Int, 110, 369, 10.1111/j.1464-410X.2011.10926.x

Pepe, 2013, Morbidity following transperineal prostate biopsy in 3,000 patients submitted to 12 vs 18 vs more than 24 needle cores, Urology, 81, 1142, 10.1016/j.urology.2013.02.019

Lecouvet, 2012, Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace 99m Tc bone scanning and computed tomography for single-step detection of metastases in patients with high risk prostate cancer?, Eur Urol, 62, 68, 10.1016/j.eururo.2012.02.020

Schroder, 2009, Screening of prostate cancer mortality in randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084